Holen Sie sich die Stockscreener-App
0.32
6.63%
0.0199
Vorhandelsmarkt:
.32
Schlusskurs vom Vortag:
$0.3001
Offen:
$0.33
24-Stunden-Volumen:
210.98K
Relative Volume:
0.11
Marktkapitalisierung:
$3.20M
Einnahmen:
$4.02M
Nettoeinkommen (Verlust:
$-4.73M
KGV:
-0.076
EPS:
-4.21
Netto-Cashflow:
$-5.85M
1W Leistung:
+3.06%
1M Leistung:
+8.70%
6M Leistung:
-25.58%
1J Leistung:
-73.55%
1-Tages-Spanne:
$0.3004
$0.33
1-Wochen-Bereich:
$0.288
$0.33
52-Wochen-Spanne:
$0.2208
$2.27
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
Firmenname
Petros Pharmaceuticals Inc
Sektor
Telefon
973-242-0005
Adresse
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Vergleichen Sie PTPI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.32 | 3.20M | 4.02M | -4.73M | -5.85M | -4.21 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Petros Pharmaceuticals Inc Aktie (PTPI) Neueste Nachrichten
Comparing Petros Pharmaceuticals (NASDAQ:PTPI) & MoonLake Immunotherapeutics (NASDAQ:MLTX) - Defense World
Petronas may cut capex up to RM10b after Petro gas deal - The Malaysian Reserve
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com
GROUPIRA Co-Founder Petros Koumantaros Appointed to Washington Saves Governing Board - Yahoo Finance
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules - AccessWire
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Siga Technologies (SIGA) Stock Surges Over 5% Amid Market Activi - GuruFocus.com
Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment” - AccessWire
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Siga Technologies (SIGA) Stock Drops 5.01% Amid Market Volatilit - GuruFocus.com
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Falcon’s Beyond Global Announces Mandatory Exchange of WarrantsOn December 16, 2024, Falcon’s Beyond Global, Inc. (NASDAQ: FBYD) made a significant announcement regarding the mandatory exchange of its outstanding warrants. The company reve - Defense World
Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually - AccessWire
Petros Pharmaceuticals faces financial obligation acceleration - Investing.com
Petros Pharmaceuticals, Inc. Announces Proprietary Technology Addressing the Rx-To-OTC Switch Self-Care Market Valued at over $38 Billion Annual - Marketscreener.com
Tarsus Pharmaceuticals: Worthy Of A Small Bet (NASDAQ:TARS❌ Ilumine seu dia com Estrela BRT - Oficjalny Portal Gminy Brzesko
Petros Pharmaceuticals faces financial obligation acceleration By Investing.com - Investing.com UK
Why Mitek Systems Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Helios Towers (LON:HTWS) Trading 0.1% Higher – Should You Buy? - Defense World
Cleanaway Waste Management (OTCMKTS:TSPCF) Stock Price Up 2.2% – Should You Buy? - Defense World
First National of Nebraska (OTCMKTS:FINN) Trading 0.8% Higher – Should You Buy? - Defense World
Petros Pharmaceuticals (NASDAQ:PTPI) Stock Price Down 5.8% – Should You Sell? - Defense World
Kuke Music (NYSE:KUKE) Shares Down 8.3% – Time to Sell? - Defense World
Patriot One Technologies (OTCMKTS:PTOTF) Stock Price Down 2.1% – What’s Next? - Defense World
Erectile Dysfunction Drugs Market Size, Growth Outlook 2025 – 2034 - Global Market Insights
Petros Pharmaceuticals announces shareholder meeting outcomes - Investing.com
Petros Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Petros Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Petros Pharmaceuticals stock hits 52-week low at $0.28 - Investing.com
Petros Pharmaceuticals stock hits 52-week low at $0.28 By Investing.com - Investing.com Canada
It's Probably Less Likely That Petros Pharmaceuticals, Inc.'s (NASDAQ:PTPI) CEO Will See A Huge Pay Rise This Year - Simply Wall St
Bragg Gaming Group (OTCMKTS:BRGGD) Shares Down 2.2% – What’s Next? - Defense World
Short Interest in Zions Bancorporation N.A. – 6.9 (NASDAQ:ZIONL) Increases By 170.0% - Defense World
Petros Pharmaceuticals Amends President’s Employment Terms - Yahoo Finance
Petros Pharmaceuticals adjusts executive's salary and terms - Investing.com India
Petros Pharmaceuticals adjusts executive's salary and terms By Investing.com - Investing.com South Africa
Petros Pharmaceuticals amends preferred stock terms - Investing.com India
Petros Pharmaceuticals amends preferred stock terms By Investing.com - Investing.com UK
Petros Pharmaceuticals sees two board members resign By Investing.com - Investing.com Australia
Petros Pharmaceuticals sees two board members resign - Investing.com India
Board Reshuffle at Petros Pharmaceuticals Following Resignations - TipRanks
Petros Pharmaceuticals, Inc. Announces Board Resignations - Marketscreener.com
Stock Market Trending News - StockTitan
Otsuka and Lundbeck Announce Barbara Corcoran Led Campaign to Raise Awareness of Alzheimer’s Dementia - Pharmaceutical Executive
Petros Pharmaceuticals sets date for 2024 annual meeting - Investing.com
Petros Pharmaceuticals reports high comprehension in drug app study - Investing.com
Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - AccessWire
Finanzdaten der Petros Pharmaceuticals Inc-Aktie (PTPI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):